Market Tracker

01/24 5:16pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.5799
Delayed Data
As of 4:02pm ET
 -0.0095 / -1.61%
Today’s Change
0.26
Today|||52-Week Range
1.51
-9.04%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.59
Today’s open0.58
Day’s range0.57 - 0.59
Volume510,308
Average volume (3 months)985,995
Market cap$91.8M
Dividend yield--
Data as of 4:02pm ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.15%
P/E ratioNM
Price/Sales15.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CPRXCatalyst Pharmaceuti...-0.03-2.54%
CPIXCumberland Pharmaceu...+0.01+0.17%
INFIInfinity Pharmaceuti...-0.02-0.96%
GEMPGemphire Therapeutic...-0.44-4.19%
Data as of 4:00pm ET, 01/24/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$13.2M
Annual profit (last year)-$27.6M
Net profit margin-213.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mike M. Goldberg
Chief Operating &
Financial Officer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts